Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended and read with schedule III of aforesaid regulations dated 30 January 2026 the Board of Directors of the Company in their meeting held on 29 May 2026 has inter alia approved the incorporation of a wholly owned subsidiary by the name Earkart Pharmaceuticals Private Limited and Earkart Healthcare Services Private Limited.
Earkart: Announcement under Regulation 30 (LODR)-Acquisition
May 30, 2026
Download PDF
Earkart
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month